142 related articles for article (PubMed ID: 32382087)
1. Enhanced insulin receptor interaction by a bifunctional insulin-transferrin fusion protein: an approach to overcome insulin resistance.
Liu Y; Wang HY; Shao J; Zaro JL; Shen WC
Sci Rep; 2020 May; 10(1):7724. PubMed ID: 32382087
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution, activation, and retention of proinsulin-transferrin fusion protein in the liver: Mechanism of liver-targeting as an insulin prodrug.
Liu Y; Wang HY; Zhou L; Su Y; Shen WC
J Control Release; 2018 Apr; 275():186-191. PubMed ID: 29471040
[TBL] [Abstract][Full Text] [Related]
3. Proinsulin-Transferrin Fusion Protein Exhibits a Prolonged and Selective Effect on the Control of Hepatic Glucose Production in an Experimental Model of Type 1 Diabetes.
Shao J; Zaro JL; Shen WC
Mol Pharm; 2016 Aug; 13(8):2641-6. PubMed ID: 27280852
[TBL] [Abstract][Full Text] [Related]
4. Receptor-mediated activation of a proinsulin-transferrin fusion protein in hepatoma cells.
Wang Y; Chen YS; Zaro JL; Shen WC
J Control Release; 2011 Nov; 155(3):386-92. PubMed ID: 21756950
[TBL] [Abstract][Full Text] [Related]
5. Characterization and Oral Delivery of Proinsulin-Transferrin Fusion Protein Expressed Using ExpressTec.
Chen YS; Zaro JL; Zhang D; Huang N; Simon A; Shen WC
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29373562
[TBL] [Abstract][Full Text] [Related]
6. Proinsulin-transferrin fusion protein as a novel long-acting insulin analog for the inhibition of hepatic glucose production.
Wang Y; Shao J; Zaro JL; Shen WC
Diabetes; 2014 May; 63(5):1779-88. PubMed ID: 24353179
[TBL] [Abstract][Full Text] [Related]
7. Tyrphostin-8 enhances transferrin receptor-mediated transcytosis in Caco-2- cells and inreases hypoglycemic effect of orally administered insulin-transferrin conjugate in diabetic rats.
Xia CQ; Shen WC
Pharm Res; 2001 Feb; 18(2):191-5. PubMed ID: 11405290
[TBL] [Abstract][Full Text] [Related]
8. Aberrant liver insulin receptor isoform a expression normalises with remission of type 2 diabetes after gastric bypass surgery.
Besic V; Shi H; Stubbs RS; Hayes MT
PLoS One; 2015; 10(3):e0119270. PubMed ID: 25742416
[TBL] [Abstract][Full Text] [Related]
9. Yunpi Heluo decoction attenuates insulin resistance by regulating liver miR-29a-3p in Zucker diabetic fatty rats.
Mao ZJ; Weng SY; Lin M; Chai KF
J Ethnopharmacol; 2019 Oct; 243():111966. PubMed ID: 31128151
[TBL] [Abstract][Full Text] [Related]
10. Caveolin gene transfer improves glucose metabolism in diabetic mice.
Otsu K; Toya Y; Oshikawa J; Kurotani R; Yazawa T; Sato M; Yokoyama U; Umemura S; Minamisawa S; Okumura S; Ishikawa Y
Am J Physiol Cell Physiol; 2010 Mar; 298(3):C450-6. PubMed ID: 19923424
[TBL] [Abstract][Full Text] [Related]
11. Borapetoside C from Tinospora crispa improves insulin sensitivity in diabetic mice.
Ruan CT; Lam SH; Chi TC; Lee SS; Su MJ
Phytomedicine; 2012 Jun; 19(8-9):719-24. PubMed ID: 22579212
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin-mimetic peptides (TXM) inhibit inflammatory pathways associated with high-glucose and oxidative stress.
Lejnev K; Khomsky L; Bokvist K; Mistriel-Zerbib S; Naveh T; Farb TB; Alsina-Fernandez J; Atlas D
Free Radic Biol Med; 2016 Oct; 99():557-571. PubMed ID: 27658743
[TBL] [Abstract][Full Text] [Related]
13. DhHP-6 ameliorates hepatic oxidative stress and insulin resistance in type 2 diabetes mellitus through the PI3K/AKT and AMPK pathway.
Wang K; Liang Y; Su Y; Wang L
Biochem J; 2020 Jun; 477(12):2363-2381. PubMed ID: 32510127
[TBL] [Abstract][Full Text] [Related]
14. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
[TBL] [Abstract][Full Text] [Related]
15. Iron overload by transferrin receptor protein 1 regulation plays an important role in palmitate-induced insulin resistance in human skeletal muscle cells.
Cui R; Choi SE; Kim TH; Lee HJ; Lee SJ; Kang Y; Jeon JY; Kim HJ; Lee KW
FASEB J; 2019 Feb; 33(2):1771-1786. PubMed ID: 30207798
[TBL] [Abstract][Full Text] [Related]
16. The aetiology and molecular landscape of insulin resistance.
James DE; Stöckli J; Birnbaum MJ
Nat Rev Mol Cell Biol; 2021 Nov; 22(11):751-771. PubMed ID: 34285405
[TBL] [Abstract][Full Text] [Related]
17. Multiple mechanisms of GW-9508, a selective G protein-coupled receptor 40 agonist, in the regulation of glucose homeostasis and insulin sensitivity.
Ou HY; Wu HT; Hung HC; Yang YC; Wu JS; Chang CJ
Am J Physiol Endocrinol Metab; 2013 Mar; 304(6):E668-76. PubMed ID: 23341496
[TBL] [Abstract][Full Text] [Related]
18. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
Kong WJ; Zhang H; Song DQ; Xue R; Zhao W; Wei J; Wang YM; Shan N; Zhou ZX; Yang P; You XF; Li ZR; Si SY; Zhao LX; Pan HN; Jiang JD
Metabolism; 2009 Jan; 58(1):109-19. PubMed ID: 19059538
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats.
Xia CQ; Wang J; Shen WC
J Pharmacol Exp Ther; 2000 Nov; 295(2):594-600. PubMed ID: 11046093
[TBL] [Abstract][Full Text] [Related]
20. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
